The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Tuberous sclerosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hamartin and tuberin, the protein products of TSC1 and TSC2, inhibit mammalian target of rapamycin (mTOR) (41).”
From Modeling Autistic Features in Animals (2011) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Self-citationIdentification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products
van Slegtenhorst, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.6.1053 · Cited by 565
Research works printed but not linked: 49
- Curatolo P (ed): Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes. London: Mac Keith Press, 2003.
- Guertin DA, Sabatini DM : An expanding role for mTOR in cancer. Trends Mol Med 2005; 11: 353–361. · DOI · Paper page
- Inoki K, Corradetti MN, Guan KL : Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005; 37: 19–24. · DOI · Paper page
- Yates JRW : Tuberous Sclerosis; in Cassidy SB, Allanson JE (eds): Management of Genetic Syndromes. Hoboken, New Jersey: John Wiley & Sons, 2005.
- Gomez MR, Sampson JR, Whittemore VH (eds): Tuberous Sclerosis Complex. Oxford: Oxford University Press, 1999. · DOI · Paper page
- Joinson C, O'Callaghan FJ, Osborne JP, Martyn C, Harris T, Bolton PF : Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 2003; 33: 335–344. · DOI · Paper page
- O'Callaghan FJ, Harris T, Joinson C et al: The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child 2004; 89: 530–533. · DOI · Paper page
- Gillberg IC, Gillberg C, Ahlsen G : Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study. Dev Med Child Neurol 1994; 36: 50–56. · DOI · Paper page
- Shepherd CW, Houser OW, Gomez MR : MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. Am J Neuroradiol 1995; 16: 149–155.
- Bolton PF, Park RJ, Higgins JN, Griffiths PD, Pickles A : Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 2002; 125: 1247–1255. · DOI · Paper page
- Rowley SA, O'Callaghan FJ, Osborne JP : Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol 2001; 85: 420–423. · DOI · Paper page
- Tworetzky W, McElhinney DB, Margossian R et al: Association between cardiac tumors and tuberous sclerosis in the fetus and neonate. Am J Cardiol 2003; 92: 487–489. · DOI · Paper page
- Sampson JR, Maheshwar MM, Aspinwall R et al: Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 1997; 61: 843–851. · DOI · Paper page
- Nelson CP, Sanda MG : Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002; 168: 1315–1325. · DOI · Paper page
- Hancock E, Tomkins S, Sampson J, Osborne J : Lymphangioleiomyomatosis and tuberous sclerosis. Respir Med 2002; 96: 7–13. · DOI
- Roach ES, Gomez MR, Northrup H : Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998; 13: 624–628. · DOI · Paper page
- Kwiatkowska J, Wigowska-Sowinska J, Napierala D, Slomski R, Kwiatkowski DJ : Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. N Engl J Med 1999; 340: 703–707. · DOI
- Jones AC, Shyamsundar MM, Thomas MW et al: Comprehensive mutation analysis of TSC1 and TSC2 – and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999; 64: 1305–1315. · DOI · Paper page
- Dabora SL, Jozwiak S, Franz DN et al: Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001; 68: 64–80. · DOI · Paper page
- Sancak O, Nellist M, Goedbloed M et al: Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur J Hum Genet 2005; 13: 731–741. · DOI · Paper page
- Lewis JC, Thomas HV, Murphy KC, Sampson JR : Genotype and psychological phenotype in tuberous sclerosis. J Med Genet 2004; 41: 203–207. · DOI
- Mayer K, Goedbloed M, van Zijl K, Nellist M, Rott HD : Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis. J Med Genet 2004; 41: e64. · DOI
- O'Connor SE, Kwiatkowski DJ, Roberts PS, Wollmann RL, Huttenlocher PR : A family with seizures and minor features of tuberous sclerosis and a novel TSC2 mutation. Neurology 2003; 61: 409–412. · DOI
- Dabora SL, Roberts P, Nieto A et al: Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. Am J Hum Genet 2002; 71: 750–758. · DOI
- Verhoef S, Bakker L, Tempelaars AM et al: High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet 1999; 64: 1632–1637. · DOI · Paper page
- Yates JR, van Bakel I, Sepp T et al: Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis. Hum Mol Genet 1997; 6: 2265–2269. · DOI
- Green AJ, Johnson PH, Yates JR : The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 1994; 3: 1833–1834. · DOI · Paper page
- Green AJ, Smith M, Yates JR : Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 1994; 6: 193–196. · DOI · Paper page
- Carsillo T, Astrinidis A, Henske EP : Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 2000; 97: 6085–6090. · DOI · Paper page
- Yu J, Astrinidis A, Henske EP : Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am J Respir Crit Care Med 2001; 164: 1537–1540. · DOI · Paper page
- Plank TL, Yeung RS, Henske EP : Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 1998; 58: 4766–4770.
- Manning BD, Cantley LC : Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 2003; 28: 573–576. · DOI · Paper page
- Kwiatkowski DJ, Manning BD : Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 2005; 14 (Spec no. 2): R251–R258. · DOI · Paper page
- Kenerson H, Dundon TA, Yeung RS : Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res 2005; 57: 67–75. · DOI · Paper page
- Lee L, Sudentas P, Donohue B et al: Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosomes Cancer 2005; 42: 213–227. · DOI · Paper page
- Roach ES, DiMario FJ, Kandt RS, Northrup H : Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol 1999; 14: 401–407. · DOI · Paper page
- Hancock E, Osborne JP : Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 1999; 14: 71–74. · DOI
- Vanhatalo S, Nousiainen I, Eriksson K et al: Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia 2002; 43: 748–756. · DOI
- Jarrar RG, Buchhalter JR, Raffel C : Long-term outcome of epilepsy surgery in patients with tuberous sclerosis. Neurology 2004; 62: 479–481. · DOI
- Parain D, Penniello MJ, Berquen P, Delangre T, Billard C, Murphy JV : Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 2001; 25: 213–216. · DOI
- Torres OA, Roach ES, Delgado MR et al: Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis. J Child Neurol 1998; 13: 173–177. · DOI
- Goh S, Kwiatkowski DJ, Dorer DJ, Thiele EA : Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 2005; 65: 235–238. · DOI
- Papadavid E, Markey A, Bellaney G, Walker NP : Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis. Br J Dermatol 2002; 147: 337–342. · DOI
- Johnson SR, Tattersfield AE : Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55: 1052–1057. · DOI · Paper page
- Kothary N, Soulen MC, Clark TW et al: Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol 2005; 16: 45–50. · DOI · Paper page
- Dickinson M, Ruckle H, Beaghler M, Hadley HR : Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin Nephrol 1998; 49: 281–286.
- Roach ES, Kerr J, Mendelsohn D, Laster DW, Raeside C : Detection of tuberous sclerosis in parents by magnetic resonance imaging. Neurology 1991; 41: 262–265. · doi:10.1212/wnl.41.2_part_1.262
- Fryer AE, Chalmers AH, Osborne JP : The value of investigation for genetic counselling in tuberous sclerosis. J Med Genet 1990; 27: 217–223. · DOI
- Levine D, Barnes P, Korf B, Edelman R : Tuberous sclerosis in the fetus: second-trimester diagnosis of subependymal tubers with ultrafast MR imaging. Am J Roentgenol 2000; 175: 1067–1069. · DOI
Cited by
Curatolo, P., Bombardieri, R., & Jozwiak, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61279-9 · Cited by 1,088
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051
Management of epilepsy associated with tuberous sclerosis complex (TSC): Clinical recommendations
Curatolo, P., Jóźwiak, S., & Nabbout, R. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.05.004 · Cited by 256
Modeling Autistic Features in Animals
PATTERSON, P. H. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212b80f · Cited by 188
Molecular Therapies for Tuberous Sclerosis and Neurofibromatosis
Franz, D. N., & Weiss, B. D. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0269-4 · Cited by 58
Metadata
- Authors
- Yates, J. R. W.
- Venue
- European Journal of Human Genetics
- Published
- 2006-07-26
- Volume
- 14
- Issue
- 10
- Pages
- 1065-1073
- ISSN
- 1018-4813
- 1476-5438
- Cited by
- 99
- References
- 3
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.